What diagnostic tests are recommended for evaluating dysautonomia?

Dysautonomia Testing

For most patients with suspected dysautonomia, begin with a simple 10-minute stand test measuring heart rate and blood pressure in the supine position for 5 minutes, then standing for up to 10 minutes with recordings at least 1 minute apart after the first minute 1.

Initial Clinical Assessment

Start with a detailed history focusing on:

• Orthostatic dizziness, lightheadedness, or weakness with standing
• Syncope and exercise intolerance
• Palpitations and cognitive dysfunction
• Gastrointestinal symptoms (gastroparesis, constipation, diarrhea)
• Genitourinary symptoms (urinary retention, incontinence, sexual dysfunction)
• Sweating abnormalities (increased or decreased)

Physical examination should include orthostatic vital signs and complete cardiac and neurological evaluation 1, 2.

Laboratory Testing

Obtain routine blood work to identify secondary causes 1:

• Complete blood count
• Electrolytes (Na+, K+, Cl-)
• Renal function (creatinine, urea)
• Ferritin
• Thyroid stimulating hormone
• Morning cortisol level

When to Perform Formal Autonomic Testing

Most patients do NOT need extensive autonomic testing 1. Reserve detailed autonomic evaluation for:

1. Patients who fail initial conventional therapy and have suspected autonomic neuropathy 1
2. Complicated or refractory cases requiring specialist management 1
3. Suspected small fiber polyneuropathy where autonomic testing can document dysfunction with high accuracy 3
4. Suspected autonomic neuropathy (e.g., amyloidosis, autoimmune autonomic neuropathy) 3

Comprehensive Autonomic Test Battery

When formal testing is indicated, use a validated battery of tests examining three major domains 4, 3:

Cardiovascular Autonomic Tests (Gold Standard)

These are the most established and validated tests 4:

• Heart rate response to deep breathing (parasympathetic function)
• Heart rate response to standing (parasympathetic function)
• Valsalva maneuver (both parasympathetic and sympathetic function)
  • Avoid in proliferative retinopathy or increased risk of retinal hemorrhage 4
• Blood pressure response to standing (sympathetic adrenergic function)

At least two abnormal cardiovagal tests plus orthostatic hypotension testing are required for definite diagnosis and staging of cardiovascular autonomic neuropathy 4.

Sudomotor Function Tests

• Quantitative sudomotor axon reflex test (QSART) - documents small fiber (sudomotor axon) loss with high sensitivity, particularly useful for confirming small fiber polyneuropathy 3
• Thermoregulatory sweat test (if available)
• Sympathetic skin response

Additional Specialized Tests (Select Cases Only)

• Tilt table testing - useful when diagnosis unclear after initial evaluation, particularly for suspected vasovagal syncope or delayed orthostatic hypotension 1, 5
• Plasma norepinephrine levels during orthostatic stress 1
• 24-hour urine sodium 1
• Blood volume measurement 1
• Antinicotinic ganglionic antibodies 1

Skin Biopsy for Small Fiber Neuropathy

Skin biopsy with intraepidermal nerve fiber (IENF) density assessment may be considered as an alternative or complement to autonomic testing for diagnosing small fiber sensory polyneuropathy 3. This is a validated, reproducible technique using PGP 9.5 immunohistochemistry that directly documents small fiber loss.

Critical Testing Considerations

Standardize testing conditions to minimize confounding factors 4:

• Avoid testing during acute illness, fever, infection, or dehydration
• Do not test during hypoglycemia or marked hyperglycemia
• Perform tests at least 2 hours after short-acting insulin administration
• Consider medication effects (diuretics, sympatholytic agents, psychoactive drugs require washout if possible)
• Use age-related normal ranges - age is the most relevant factor affecting heart rate tests 4
• Interpret results cautiously in patients with respiratory or cardiovascular disease, especially heart failure

Staging Autonomic Dysfunction

Progress from early to advanced involvement 4:

1. Possible/Early: One abnormal cardiovagal test (confirm over time)
2. Definite/Confirmed: At least two abnormal cardiovagal tests
3. Severe/Advanced: Orthostatic hypotension plus heart rate test abnormalities

Progressive stages correlate with increasingly worse prognosis 4.

What NOT to Do

Do not routinely order 1:

• Tilt table testing (unless diagnosis unclear after initial evaluation)
• Extensive autonomic nervous system testing
• Plasma catecholamine testing
• Autoimmune workup
• Blood volume assessment
• Neuroimaging or neurological studies (unless focal neurological deficits present)
• Echocardiogram or external ECG monitoring (unless concern for structural heart disease or non-sinus arrhythmia)

The Canadian Cardiovascular Society explicitly recommends against routine use of these tests in most POTS patients, reserving them only for diagnostic clarification or targeted therapy in select cases 1.